PDF(Sci-hub)
Abstract：
Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines (\"JSH 2019\") continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.
摘要：
与其他国际准则不同，但与早期的日本高血压协会（JSH）准则一致，2019年JSH指南(\"JSH2019\")继续强调使用家用血压装置获得的非办公室血压(BP)测量值的重要性.JSH2019的另一个独特之处在于，它基于对最新证据的系统评价，提出了有关高血压管理的临床问题。JSH2019指出，办公室血压<140/90mmHg的个人血压不正常。关于高血压的诊断和治疗的最终决定应根据办公室外的BP值以及办公室BP测量值进行。对于患有合并症的高血压成年人，办公室血压目标通常<130/80mmHg，家庭血压目标<125/75mmHg。JSH2019的建议不仅对日本高血压患者而且对亚洲高血压患者都有价值，他们具有相同的特征，包括与心肌梗死相比，卒中发生率更高，血压与血管事件的关系更陡。
